Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.65 |
| ▸ | POLB | P06746 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.58 |
| ▸ | USP2 | O75604 | 1/20 | 0.58 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.54 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.54 |
| ▸ | ERN1 | O75460 | 1/20 | 0.54 |
| ▸ | NSD2 | O96028 | 1/20 | 0.53 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.53 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29027 | 1.00 | PTPN22 (0.65) | PTPN22POLBHSD17B10CYP1A2USP2 | |
| SCHEMBL15400598 | 1.00 | PTPN22 (0.65) | PTPN22POLBHSD17B10CYP1A2USP2 | |
| Charcoal, Activated SCHEMBL30539223 | 0.97 | PTPN22 (0.62) | PTPN22POLBHSD17B10CYP1A2USP2 | |
| SCHEMBL16291794 | 0.97 | PTPN22 (0.62) | PTPN22POLBHSD17B10CYP1A2USP2 | |
| Hydrogen Sulfide SCHEMBL30378374 | 0.97 | PTPN22 (0.62) | PTPN22POLBHSD17B10CYP1A2USP2 | |
| Methane SCHEMBL10406101 | 0.97 | PTPN22 (0.62) | PTPN22POLBHSD17B10CYP1A2USP2 | |
| SCHEMBL9875431 | 0.97 | PTPN22 (0.62) | PTPN22POLBHSD17B10CYP1A2USP2 | |
| Water SCHEMBL18660620 | 0.97 | PTPN22 (0.62) | PTPN22POLBHSD17B10CYP1A2USP2 | |
| SCHEMBL8381351 | 0.95 | PTPN22 (0.60) | PTPN22POLBHSD17B10CYP1A2USP2 | |
| Lithium SCHEMBL30861675 | 0.95 | PTPN22 (0.60) | PTPN22POLBHSD17B10CYP1A2USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 738 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122010956-A | Chiral 1, 4-diazabicyclo [3.1.1] heptane derivatives, synthesis and application thereof | 浙江师范大学 | 2026-05-12 | — | — | CN | claimed |
| EP-4731727-A1 | HALF-WAVE PLATE | Merck Patent GmbH (DE) | 2026-04-29 | — | — | EP | claimed |
| EP-4713414-A1 | OPTICAL ELEMENT COMPRISING A CHIRAL LC POLYMER FILM | Merck Patent GmbH (DE) | 2026-03-25 | — | — | EP | claimed |
| EP-4713413-A1 | CHIRAL REACTIVE MESOGEN MIXTURE | Merck Patent GmbH (DE) | 2026-03-25 | — | — | EP | claimed |
| EP-4067333-B1 | METHOD FOR PRODUCING BINAPHTHYL CARBOXYLIC ACID | HONSHU CHEMICAL IND (JP) | 2026-02-18 | — | — | EP | claimed |
| EP-4284778-B1 | METHOD FOR PREPARING LEVETIRACETAM AND INTERMEDIATES THEREOF | SUZHOU BRIGHTHOPE PHARMATECH CO LTD (CN) | 2025-12-17 | — | — | EP | claimed |
| EP-4067331-B1 | PREPARATION METHOD FOR 2,2'-BIS(CARBOXYMETHOXY)-1,1'-BINAPHTHYL | HONSHU CHEMICAL IND (JP) | 2025-10-29 | — | — | EP | claimed |
| US-20250270230-A1 | NOVEL SYNTHETIC STEPS FOR THE MANUFACTURING METHOD OF THE PDE4B-INHIBITOR 1-({(5R)-2-[4-(5-CHLOROPYRIMIDINE-2-YL)PIPERIDINE-1-YL]-5-OXIDO-6,7-DIHYDROTHIENO[3,2-D]PYRIMIDINE-4-YL}AMINO)CYCLOBUTYL]METHANOL | BOEHRINGER INGELHEIM INT (DE) | 2025-08-28 | — | — | US | claimed |
| WO-2025131986-A1 | NOVEL SYNTHETIC STEPS FOR THE MANUFACTURING METHOD OF THE PDE4B-INHIBITOR 1-({(5R)-2-[4-(5-CHLOROPYRIMIDINE-2-YL)PIPERIDINE-1-YL]-5-OXIDO-6,7-DIHYDROTHIENO[3,2-D]PYRIMIDINE-4-YL}AMINO)CYCLOBUTYL]METHANOL | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2025-06-26 | — | — | WO | claimed |
| CN-119912893-B | Curing adhesive, S-type epoxy compound with binaphthyl, preparation method and application | 宁波天璇新材料科技有限公司 | 2025-06-17 | — | — | CN | claimed |
| CN-114478245-A | Asymmetric synthesis method of chiral gamma-alkynyl-alpha-keto acid ester compound | 青岛科技大学 | 2022-05-13 | — | — | CN | claimed |
| CN-114456051-A | Chiral binaphthyl beta-diketone rare earth circular polarization luminous spirochaete and preparation method thereof | 黑龙江大学 | 2022-05-10 | — | — | CN | claimed |
| CN-112574003-B | Method for efficiently preparing 1, 1' -bi-2-naphthol by solid ligand assisted catalysis | 中唯炼焦技术国家工程研究中心有限责任公司 | 2022-05-10 | — | — | CN | claimed |
| CN-114409592-A | Biaryl structure chiral pyridoxal catalyst with side chain at C3 position as well as preparation method and application thereof | 上海师范大学 | 2022-04-29 | — | — | CN | claimed |
| WO-2022085509-A1 | COLORED LIQUID, COLORED-LIQUID SET, RECORDING MEDIUM, AND COLORING METHOD | 日本化薬株式会社 | 2022-04-28 | — | — | WO | claimed |
| CN-109810057-B | Method for synthesizing chiral isoquinoline by palladium-catalyzed asymmetric C-H bond amine carbonylation | 中国科学院兰州化学物理研究所 | 2022-04-26 | — | — | CN | claimed |
| CN-114292286-A | Chiral organic-inorganic hybrid copper (I) halide crystal and preparation method and application thereof | 南开大学 | 2022-04-08 | — | — | CN | claimed |
| CN-114280134-A | Reagent and method for analyzing enantiomer structures of two-paired binaphthyl derivatives | 宁波大学 | 2022-04-05 | — | — | CN | claimed |
| CN-114249635-A | Novel chiral (R) -binaphthol titanium complex and preparation method and application thereof | 山西医科大学 | 2022-03-29 | — | — | CN | claimed |
| CN-114213465-A | Ir (III) -based chiral metal-organic porous material with resolution function, and preparation method and application thereof | 大连理工大学 | 2022-03-22 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250270230-A1 | NOVEL SYNTHETIC STEPS FOR THE MANUFACTURING METHOD OF THE PDE4B-INHIBITOR 1-({(5R)-2-[4-(5-CHLOROPYRIMIDINE-2-YL)PIPERIDINE-1-YL]-5-OXIDO-6,7-DIHYDROTHIENO[3,2-D]PYRIMIDINE-4-YL}AMINO)CYCLOBUTYL]METHANOL | PDE4B, PDE3B, PDE5A | PTPN22 1109/4885POLB 187/4885HSD17B10 1260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.